EUVIMEDEUVIMED entdecken
Querschnittstudie

Stigma experienced by people with drug-resistant tuberculosis in Lagos, Nigeria: a cross-sectional study

Olusola A Adejumo iD, Champaklal Jinabhai, Olusoji Daniel, Firoza Haffejee

Transactions of The Royal Society of Tropical Medicine and Hygiene · 2025

DOI: 10.1093/trstmh/traf026 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Transactions of The Royal Society of Tropical Medicine and Hygiene, 2025. Verfasst von Olusola A Adejumo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mainland Hospital Yaba, Lagos Nigeria. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Social Stigma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Lagos State Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tuberculosis (TB) stigma is one of the factors responsible for low notification rates in Nigeria, especially among people with drug-resistant TB (DR-TB). This study assessed the factors associated with stigma among people with DR-TB in Lagos, Nigeria.

Methods

A descriptive cross-sectional study was conducted among 203 adults on DR-TB treatment. The Redwood DR-TB stigma scale was used to assess the stigma experienced by people with DR-TB. A logistic regression model was used to evaluate the factors associated with TB stigma.

Results

The prevalence of TB stigma was 65.5%. Being male (adjusted odds ratio [aOR] 2.59 [95% confidence interval {CI} 1.03 to 6.50], p=0.042), not earning an income (aOR 2.57 [95% CI 1.84 to 7.85], p=0.039), substance use (alcohol or cigarette smoking; aOR 1.61 [95% CI 1.06 to 3.88], p=0.028) and the duration of the DR-TB diagnosis (aOR 2.72 [95% CI 1.94 to 3.83], p<0.001) were associated with stigma among people with DR-TB. Human immunodeficiency virus (HIV)-negative participants experienced TB stigma 2.4 times more (crude OR 2.4 [95% CI 1.14 to 5.04], p=0.021) than HIV-positive participants, although the relationship was not sustained in the multivariate analysis.

Conclusions

Having identified the factors associated with stigma in this target population, it is imperative to address and control them among DR-TB patients in Lagos, Nigeria. The urgent need for stigma reduction strategies cannot be overemphasized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, Multidrug-ResistantSocial StigmaHumansMaleNigeriaCross-Sectional StudiesFemaleAdultMiddle AgedYoung AdultPrevalenceAdolescentLogistic ModelsSocioeconomic FactorsRisk Factors

Stichwörter der Autor:innen

Nigeriadrug-resistant tuberculosisexperienced stigmatuberculosis stigma

Autor:innen und Institutionen

  • Mainland Hospital Yaba, Lagos Nigeria.
  • Department of Basic Medical Sciences, Durban University of Technology, Durban, South Africa.
  • Faculty of Health Sciences, Durban University of Technology, Durban, South Africa.
  • Department of Community Medicine and Primary Care, Olabisi Onabanjo University, Sagamu, Nigeria.

ORCID-Profile: Olusola A Adejumo

Förderung

  • Lagos State Ministry of Health

Zitieren

APA

Adejumo, O. A., Jinabhai, C., Daniel, O., & Haffejee, F. (2025). Stigma experienced by people with drug-resistant tuberculosis in Lagos, Nigeria: a cross-sectional study. Transactions of The Royal Society of Tropical Medicine and Hygiene. https://doi.org/10.1093/trstmh/traf026

Vancouver

Adejumo OA, Jinabhai C, Daniel O, Haffejee F. Stigma experienced by people with drug-resistant tuberculosis in Lagos, Nigeria: a cross-sectional study. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2025. doi:10.1093/trstmh/traf026

BibTeX
@article{Adejumo2025,
  author = {Adejumo, Olusola A and Jinabhai, Champaklal and Daniel, Olusoji and Haffejee, Firoza},
  title = {Stigma experienced by people with drug-resistant tuberculosis in Lagos, Nigeria: a cross-sectional study},
  journal = {Transactions of The Royal Society of Tropical Medicine and Hygiene},
  year = {2025},
  doi = {10.1093/trstmh/traf026}
}
Kostenlos starten →